Analytical Approaches for the Determination of Antineoplastic Agent: A Review

Cancer is one of the leading causes of death worldwide and represents a major public health challenge. It is characterized by the uncontrolled growth and division of abnormal cells, which can invade surrounding tissues and spread to different parts of the body through a process known as metastasis. According to the World Health Organization (WHO), cancer accounts for millions of deaths every year, making effective diagnosis, treatment, and monitoring essential for improving patient outcomes.¹ Antineoplastic agents, commonly known as anticancer drugs, are medications used to prevent, inhibit, or destroy the growth of cancer cells. These drugs act through various mechanisms such as inhibiting DNA synthesis, blocking cell division, inducing apoptosis, and interfering with specific molecular targets involved in tumor progression². Antineoplastic drugs are classified into several categories, including alkylating agents, antimetabolites, antitumor antibiotics, plant alkaloids, hormonal agents, monoclonal antibodies, and targeted therapies. The introduction of targeted anticancer agents has significantly improved treatment outcomes while reducing adverse effects associated with conventional chemotherapy.³

The growing use of antineoplastic drugs in clinical practice has increased the need for accurate and reliable analytical methods for their determination. Analytical methods play an important role in pharmaceutical research, drug development, quality control, pharmacokinetic studies, therapeutic drug monitoring, and stability testing. Reliable analytical techniques ensure that pharmaceutical products meet the required quality standards and contain the correct amount of active pharmaceutical ingredient (API) throughout their shelf life.⁴ .Various analytical techniques have been developed for the determination of antineoplastic agents in pharmaceutical formulations and biological samples. Among these techniques, spectrophotometric methods are widely used because they are simple, cost-effective, and suitable for routine analysis. Ultraviolet-visible (UV-Vis) spectrophotometry is commonly employed for the quantitative estimation of anticancer drugs due to its ease of operation and minimal sample preparation requirements. However, spectrophotometric methods may lack selectivity when complex mixtures or degradation products are present.⁵ Chromatographic techniques are considered the most important analytical tools for the determination of antineoplastic agents. High-performance liquid chromatography (HPLC) is one of the most widely used techniques because of its high sensitivity, accuracy, precision, and reproducibility. HPLC enables the separation and quantification of active pharmaceutical ingredients, impurities, and degradation products within a single analysis. Reverse-phase HPLC (RP-HPLC) is particularly popular due to its versatility and suitability for a wide range of anticancer drugs.⁶

In recent years, advanced chromatographic techniques such as ultra-performance liquid chromatography (UPLC) and liquid chromatography coupled with mass spectrometry (LC-MS/MS) have gained considerable attention. UPLC provides faster analysis, improved resolution, and reduced solvent consumption compared to conventional HPLC. LC-MS/MS combines the separation capability of liquid chromatography with the detection sensitivity of mass spectrometry, making it highly suitable for trace-level analysis in biological matrices such as plasma, serum, and urine.⁷ Analytical methods are also essential for studying the stability of antineoplastic agents. During manufacturing, storage, and transportation, drugs may undergo degradation due to exposure to heat, light, moisture, oxygen, and other environmental factors. Stability-indicating methods are specifically designed to separate and quantify degradation products while accurately measuring the intact drug substance. These methods are crucial for ensuring the safety, efficacy, and quality of pharmaceutical products.⁸ Method development is a critical step in analytical research. Traditionally, analytical methods were developed using a trial-and-error approach, where one factor was varied at a time while keeping other factors constant. Although this approach is simple, it is time-consuming and may fail to identify interactions between variables. As a result, regulatory agencies now encourage the use of systematic and scientific approaches for analytical method development.⁹

Quality by Design (QbD) has emerged as an effective strategy for developing robust analytical methods. QbD is a science-based and risk-oriented approach that focuses on understanding the relationship between method parameters and analytical performance. The process begins with defining the Analytical Target Profile (ATP), which specifies the desired performance characteristics of the analytical method. Critical Quality Attributes (CQAs) such as retention time, resolution, peak symmetry, and theoretical plates are then identified and monitored throughout method development.¹⁰ Risk assessment tools such as Ishikawa diagrams and Failure Mode and Effects Analysis (FMEA) are commonly used to identify factors that may affect method performance. Critical Method Parameters (CMPs), including mobile phase composition, pH, flow rate, column temperature, and detection wavelength, are evaluated to determine their impact on analytical results. This systematic approach helps improve method understanding and robustness.¹¹

Design of Experiments (DoE) is another important component of modern analytical development. DoE allows the simultaneous evaluation of multiple variables and their interactions using statistical techniques. Experimental designs such as factorial designs, Box–Behnken designs, and central composite designs are frequently used for method optimization. The use of DoE reduces the number of experiments required while providing comprehensive information about the analytical process¹². Method validation is performed to demonstrate that an analytical method is suitable for its intended purpose. According to the International Council for Harmonisation (ICH) guidelines, validation parameters include specificity, linearity, accuracy, precision, limit of detection (LOD), limit of quantification (LOQ), robustness, and system suitability. Validation ensures that the developed method consistently produces reliable and reproducible results.¹³ Recent advancements in analytical instrumentation, software, and regulatory expectations have significantly improved the determination of antineoplastic agents. The integration of chromatographic techniques with Quality by Design principles, risk assessment, and statistical optimization has enabled the development of highly sensitive, accurate, and robust analytical methods. These methods play a vital role in ensuring the quality, safety, and effectiveness of anticancer drugs throughout their lifecycle.¹⁴

Therefore, this review aims to provide a comprehensive overview of the analytical approaches used for the determination of antineoplastic agents, with particular emphasis on chromatographic techniques, method development strategies, Quality by Design concepts, validation requirements, and recent advancements in pharmaceutical analysis.

1. Chromatographic techniques

Chromatographic techniques are widely used analytical methods for the separation, identification, and quantification of pharmaceutical compounds. These techniques offer high sensitivity, accuracy, and reproducibility, making them suitable for the analysis of antineoplastic agents. Chromatography can effectively separate drugs from impurities, degradation products, and excipients present in formulations. Due to their reliability and versatility, chromatographic methods are extensively employed in pharmaceutical research, quality control, and stability studies.

Table 1: Common Chromatographic Techniques Used for Analysis of Antineoplastic Agents^15-17

Method Development Strategies for the Determination of Antineoplastic Agents

Analytical method development is a systematic process used to establish a reliable, accurate, and robust method for the analysis of pharmaceutical compounds. In the case of antineoplastic agents, method development is essential to ensure accurate quantification, impurity profiling, stability assessment, and quality control. A well-developed analytical method should provide adequate specificity, sensitivity, precision, and reproducibility while complying with regulatory requirements. Modern analytical development focuses on understanding method variables and their impact on analytical performance through scientific and risk-based approaches.

Table 2: Major Steps in Analytical Method Development^18-20

Quality by Design (QbD)-Based Method Development Strategy^20-22

The Quality by Design (QbD) approach is increasingly used for analytical method development because it provides a systematic understanding of method variables and their impact on analytical performance. The key components include:

1. Analytical Target Profile (ATP): Defines the intended purpose and performance requirements of the analytical method.
2. Critical Quality Attributes (CQAs): Analytical responses such as retention time, resolution, theoretical plates, and tailing factor.
3. Risk Assessment: Identification of Critical Method Parameters (CMPs) using Ishikawa diagrams and FMEA.
4. Design of Experiments (DoE): Statistical optimization of method parameters.
5. Method Operable Design Region (MODR): Establishment of a multidimensional design space ensuring consistent method performance.
6. Method Validation: Confirmation that the optimized method meets regulatory requirements.

Quality by Design (QbD) Concepts^23-25

Quality by Design (QbD) is a systematic, science-based, and risk-oriented approach used for analytical method development. Instead of relying on trial-and-error experiments, QbD focuses on understanding the relationship between method variables and analytical performance. The main objective of QbD is to develop robust and reliable analytical methods that consistently meet predefined quality requirements. Regulatory guidelines such as ICH Q14 encourage the use of QbD principles for analytical procedure development.

1. Analytical Target Profile (ATP)

The Analytical Target Profile (ATP) defines the purpose of the analytical method and specifies the required performance criteria. It serves as the foundation for method development and ensures that the analytical procedure meets its intended objectives.

2. Critical Quality Attributes (CQAs)

Critical Quality Attributes are the measurable analytical characteristics that determine method performance. Common CQAs include retention time, resolution, peak area, tailing factor, and theoretical plate count.

3. Risk Assessment

Risk assessment is performed to identify factors that may affect analytical method performance. Tools such as Ishikawa diagrams and Failure Mode and Effects Analysis (FMEA) are commonly used to evaluate potential risks.

4. Critical Method Parameters (CMPs)

Critical Method Parameters are the variables that significantly influence the analytical results. Examples include mobile phase composition, buffer pH, flow rate, column temperature, and detection wavelength.

5. Design of Experiments (DoE)

Design of Experiments is a statistical approach used to study the effect of multiple variables simultaneously. It helps in method optimization and provides a better understanding of parameter interactions.

6. Method Operable Design Region (MODR)

The Method Operable Design Region is the range of method parameters within which the analytical method consistently produces acceptable results. It ensures method robustness and reliability.

7. Control Strategy

A control strategy consists of predefined controls and monitoring procedures used to maintain consistent analytical performance throughout the method lifecycle.

8. Method Validation

Method validation confirms that the developed analytical procedure is suitable for its intended purpose. Validation parameters include specificity, accuracy, precision, linearity, robustness, LOD, and LOQ.

9. Lifecycle Management

Lifecycle management involves continuous monitoring, maintenance, and improvement of the analytical method to ensure long-term performance and regulatory compliance.

Validation Requirements

Method validation is the process of demonstrating that an analytical procedure is suitable for its intended purpose. According to ICH Q2(R2), analytical methods should be validated to ensure accuracy, reliability, and reproducibility. Validation is essential before a method can be used for routine quality control testing.^26-28

Table 3: Validation Parameters as per ICH Q2(R2)